Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAXIMIN vs RILONACEPT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAXIMIN vs RILONACEPT: Safety Overview

Metric RIFAXIMIN RILONACEPT
Total FAERS Reports 13,861 843
Deaths Reported 5,009 14
Death Rate 36.1% 1.7%
Hospitalizations 4,847 65
Average Patient Age 63.2 yrs 51.9 yrs
% Female Patients 54.9% 68.2%
FDA Approval Date Mar 24, 2010 N/A
Manufacturer Salix Pharmaceuticals, Inc. Kiniksa Pharmaceuticals (UK), Ltd.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription